Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Acquired by IndexIQ Advisors LLC

IndexIQ Advisors LLC increased its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 5.1% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 2,038 shares of the medical equipment provider’s stock after purchasing an additional 99 shares during the quarter. IndexIQ Advisors LLC’s holdings in Intuitive Surgical were worth $2,026,000 at the end of the most recent quarter.

A number of other hedge funds also recently bought and sold shares of the stock. FinTrust Capital Advisors LLC lifted its holdings in Intuitive Surgical by 80.0% in the 2nd quarter. FinTrust Capital Advisors LLC now owns 36 shares of the medical equipment provider’s stock valued at $33,000 after acquiring an additional 16 shares during the last quarter. Allworth Financial LP acquired a new stake in Intuitive Surgical in the 3rd quarter valued at about $35,000. Itau Unibanco Holding S.A. acquired a new stake in Intuitive Surgical in the 2nd quarter valued at about $42,000. RPg Family Wealth Advisory LLC acquired a new stake in Intuitive Surgical in the 2nd quarter valued at about $47,000. Finally, Atwood & Palmer Inc. acquired a new stake in Intuitive Surgical in the 3rd quarter valued at about $56,000. 29.57% of the stock is owned by institutional investors and hedge funds.

Several analysts have issued reports on the company. Wells Fargo & Company boosted their price objective on Intuitive Surgical from $354.00 to $381.00 and gave the stock an “overweight” rating in a report on Wednesday, October 20th. Citigroup downgraded Intuitive Surgical from a “buy” rating to a “neutral” rating and set a $366.67 price objective on the stock. in a report on Friday, October 1st. The Goldman Sachs Group upgraded Intuitive Surgical from a “buy” rating to a “conviction-buy” rating in a report on Thursday, December 16th. Morgan Stanley upped their target price on Intuitive Surgical from $325.00 to $375.00 and gave the company an “equal weight” rating in a report on Friday, January 7th. Finally, TheStreet upgraded Intuitive Surgical from a “c+” rating to a “b” rating in a report on Monday, November 8th. Ten equities research analysts have rated the stock with a hold rating, eight have issued a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, Intuitive Surgical currently has an average rating of “Buy” and a consensus target price of $339.89.

In related news, SVP Jamie Samath sold 1,503 shares of the firm’s stock in a transaction on Friday, October 22nd. The stock was sold at an average price of $339.66, for a total value of $510,508.98. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Marshall Mohr sold 20,475 shares of the firm’s stock in a transaction on Monday, October 25th. The stock was sold at an average price of $339.20, for a total value of $6,945,120.00. The disclosure for this sale can be found here. Insiders sold 42,978 shares of company stock valued at $14,543,744 over the last three months. 0.80% of the stock is owned by company insiders.

Shares of Intuitive Surgical stock opened at $307.74 on Friday. The stock has a market capitalization of $109.94 billion, a P/E ratio of 66.42, a PEG ratio of 6.94 and a beta of 1.10. The stock has a 50 day moving average price of $343.08 and a two-hundred day moving average price of $343.45. Intuitive Surgical, Inc. has a 12-month low of $227.47 and a 12-month high of $369.69.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Monday, October 18th. The medical equipment provider reported $1.19 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.17 by $0.02. Intuitive Surgical had a return on equity of 15.98% and a net margin of 30.78%. The firm had revenue of $1.40 billion during the quarter, compared to analysts’ expectations of $1.38 billion. During the same quarter in the prior year, the business earned $2.60 earnings per share. The company’s revenue was up 30.2% on a year-over-year basis. Analysts expect that Intuitive Surgical, Inc. will post 4.45 EPS for the current year.

Intuitive Surgical Profile

Intuitive Surgical, Inc engages in the development, manufacture, and marketing of da Vinci Surgical Systems, and related instruments and accessories for invasive surgery. Its products include Da Vinci and Ion. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.

See Also: What is cost of equity?

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG).

Institutional Ownership by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.